Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

188 results for Pharmaceuticals
CLEAR ALL
Actylis
Excipient designed to be used in pharmaceutical applications.Benefits:
  • Complies with Ph Eur specifications
Actylis
Excipient for pharmaceutical applications. It gradually darkens on exposure to light.Benefits:
  • Freely soluble in water, sparingly soluble in ethanol (96%) and in alcohol
  • Insoluble in chloroform, ether and benzene
Actylis
Preservative and antimicrobial excipient for injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
Actylis
Preservative and antimicrobial excipient used in injectable formulations.Benefits:
  • Controlled metallic impurities
  • Maintains low level of endotoxins with the bioburden limits- BET/MLT
Actylis
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
  • It maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
  •  Developed for…
Actylis
Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Antioxidant and reducing agent used in injectable formulations. t is an excipient designed for solid and semi-solid dosage forms. Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Excipient designed for solid and semi-solid dosage forms. Antioxidant and reducing agent developed for injectable formulations.Benefits:
  • DMF Filed - CDE # F20200000189
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
Actylis
Preservative specially developed for solid and semi-solid dosage forms.Benefits:
  • White, odorless or almost odorless, hygroscopic, crystalline
  • Insoluble in 6N acetic acid but dissolves in hydrochloric acid